VTRS
Viatris Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum-inputs (vergelijkbare managers):
breedte van houders +9.5% ·
aandelenstroom +2.3% ·
netto nieuwe posities +8.7%
· formule
Brede accumulatie: stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 10.99M | $194.70M | n/a | −1 |
| Q2 2026 | 148 | -1 | 754.00M | $11.97B | +6 | −8 |
| Q1 2026 | 153 | +6 | 683.49M | $9.23B | +9 | −4 |
| Q4 2025 | 146 | -3 | 743.40M | $9.25B | +1 | −3 |
| Q3 2025 | 22 | -3 | 488.65M | $4.84B | n/a | −4 |
| Q2 2025 | 23 | +2 | 455.87M | $4.07B | +3 | −1 |
| Q1 2025 | 18 | -1 | 210.93M | $1.84B | +1 | −2 |
| Q4 2024 | 19 | -3 | 200.96M | $2.50B | +1 | −4 |
| Q3 2024 | 21 | +3 | 124.36M | $1.44B | +3 | n/a |
| Q2 2024 | 18 | n/a | 121.66M | $1.29B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 145.12M | n/a | $1.30B | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (passief) | 82.86M | n/a | $739.95M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 3 | T. Rowe Price ✦ | 78.77M | +5.8% | $703.44M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 4 | State Street Global Advisors ✦ (passief) | 55.29M | -10.0% | $493.72M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passief) | 31.23M | +0.2% | $278.33M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | Norges Bank ✦ (passief) | 11.54M | -7.5% | $103.09M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 7 | Glenview Capital ✦ | 8.25M | -2.9% | $73.65M | 2.1% | ▼ Trim | 5 | SEC ↗ |
| 8 | Millennium Management ✦ | 7.67M | +132.9% | $68.52M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 9 | Arrowstreet Capital ✦ | 7.53M | +1034.8% | $67.23M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 7.43M | +20.8% | $66.34M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 11 | Fidelity (FMR) ✦ | 6.79M | n/a | $60.67M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 12 | D. E. Shaw & Co. ✦ | 4.67M | Nieuw | $41.66M | 0.0% | New | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 3.21M | +47.2% | $28.69M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 14 | Gotham Asset Management ✦ | 2.71M | +232.7% | $24.20M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 948.06K | Nieuw | $8.47M | 0.0% | New | 1 | SEC ↗ |
| 16 | Marshall Wace ✦ | 580.46K | +123.7% | $5.18M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 17 | Adage Capital Partners ✦ | 480.74K | -46.3% | $4.29M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Bridgewater Associates ✦ | 341.42K | -44.1% | $3.05M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | GAMCO Investors ✦ | 294.08K | -6.4% | $2.63M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | Capital World Investors ✦ | 110.68K | 0.0% | $988,355 | 0.0% | Held | 5 | SEC ↗ |
| 21 | Two Sigma Investments ✦ | 25.78K | -98.3% | $230,251 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | Soros Fund Management ✦ | 12.30K | Nieuw | $109,866 | 0.0% | New | 1 | SEC ↗ |
| 23 | Fisher Asset Management ✦ | 10.44K | -24.5% | $93,184 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| D. E. Shaw & Co. | $41.66M | 0.0% |
| Point72 Asset Management | $8.47M | 0.0% |
| Soros Fund Management | $109,866 | 0.0% |
Verlaten
| Greenlight Capital (DME… | $52.27M | was 2.6% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1,011 houders, 984.50M aandelen, $12.02B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.